The COVID-19 Mobile Health Study (CMHS)

Chinese Alliance Against Lung Cancer

Status: Unknown

Conditions: COVID-19

Treatments: Other: nCapp, a cell phone-based auto-diagnosis system

Study type: Observational

Funder types: Other

Identifiers

NCT04275947

CAALC-008-CMHS

Details and patient eligibility

About

This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on the clinical guidelines, clinical experience, and statistic training model. We will achieve secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training cohort and 300 cases in the validation cohort.

Enrollment: 450 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• High risk of COVID-19
• RT-PCR test result of SAR2-CoV-19

Exclusion criteria

• Not available for RT-PCR test result of SAR2-CoV-19

Trial design

450 participants in 2 patient groups

Training

Treatment:

Other: nCapp, a cell phone-based auto-diagnosis system

Validation

Treatment:

Other: nCapp, a cell phone-based auto-diagnosis system